JP2015120758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015120758A5 JP2015120758A5 JP2015068513A JP2015068513A JP2015120758A5 JP 2015120758 A5 JP2015120758 A5 JP 2015120758A5 JP 2015068513 A JP2015068513 A JP 2015068513A JP 2015068513 A JP2015068513 A JP 2015068513A JP 2015120758 A5 JP2015120758 A5 JP 2015120758A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- oral administration
- dose oral
- hydrate
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- VMMKGHQPQIEGSQ-UHFFFAOYSA-N Minodronic acid Chemical compound C1=CC=CN2C(CC(O)(P(O)(O)=O)P(O)(O)=O)=CN=C21 VMMKGHQPQIEGSQ-UHFFFAOYSA-N 0.000 claims 5
- 229950011129 minodronic acid Drugs 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000011780 sodium chloride Substances 0.000 claims 5
- 239000002245 particle Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 229960001681 Croscarmellose Sodium Drugs 0.000 claims 1
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 1
- 229960000913 Crospovidone Drugs 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- 229940083542 Sodium Drugs 0.000 claims 1
- 229940091252 Sodium supplements Drugs 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 238000000748 compression moulding Methods 0.000 claims 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 238000007922 dissolution test Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 235000015424 sodium Nutrition 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015068513A JP6142892B2 (ja) | 2011-06-20 | 2015-03-30 | 経口投与用医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011136218 | 2011-06-20 | ||
| JP2011136218 | 2011-06-20 | ||
| JP2015068513A JP6142892B2 (ja) | 2011-06-20 | 2015-03-30 | 経口投与用医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012138410A Division JP5874545B2 (ja) | 2011-06-20 | 2012-06-20 | 経口投与用医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017031568A Division JP2017088626A (ja) | 2011-06-20 | 2017-02-22 | 経口投与用医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015120758A JP2015120758A (ja) | 2015-07-02 |
| JP2015120758A5 true JP2015120758A5 (fr) | 2015-08-13 |
| JP6142892B2 JP6142892B2 (ja) | 2017-06-07 |
Family
ID=47785990
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012138410A Active JP5874545B2 (ja) | 2011-06-20 | 2012-06-20 | 経口投与用医薬組成物 |
| JP2015068513A Active JP6142892B2 (ja) | 2011-06-20 | 2015-03-30 | 経口投与用医薬組成物 |
| JP2017031568A Withdrawn JP2017088626A (ja) | 2011-06-20 | 2017-02-22 | 経口投与用医薬組成物 |
| JP2018007905A Active JP6455611B2 (ja) | 2011-06-20 | 2018-01-22 | 経口投与用医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012138410A Active JP5874545B2 (ja) | 2011-06-20 | 2012-06-20 | 経口投与用医薬組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017031568A Withdrawn JP2017088626A (ja) | 2011-06-20 | 2017-02-22 | 経口投与用医薬組成物 |
| JP2018007905A Active JP6455611B2 (ja) | 2011-06-20 | 2018-01-22 | 経口投与用医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (4) | JP5874545B2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110121522B (zh) * | 2017-01-13 | 2022-06-28 | 日本制纸株式会社 | 微小球形粒子 |
| CR20230266A (es) * | 2020-12-18 | 2023-07-19 | Daewoong Pharmaceutical Co Ltd | Nueva formulación para administración oral, que comprende 1-(5-(2,4-difluorofenil)-1-((3-fluorofenil)sulfonil)-4-metoxi-1h-pirrol-3-il)-n-metilmetanamina |
| CN112972400A (zh) * | 2021-03-09 | 2021-06-18 | 华侨大学 | 可快速崩解的米诺膦酸颗粒及制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4100723B2 (ja) * | 1995-07-10 | 2008-06-11 | 旭化成ケミカルズ株式会社 | 粒剤及びその製法 |
| EP0998932A1 (fr) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Forme d'administration pharmaceutique contenant des diphosphonates ou leurs sels et méthode pour la fabriquer |
| SE9901272D0 (sv) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
| JP4394888B2 (ja) * | 2002-02-14 | 2010-01-06 | 救急薬品工業株式会社 | 経皮投与製剤 |
| KR20120065435A (ko) * | 2002-05-10 | 2012-06-20 | 에프. 호프만-라 로슈 아게 | 골다공증 치료 및 예방용 비스포스폰산 |
| JPWO2005072747A1 (ja) * | 2004-02-02 | 2007-09-13 | 小野薬品工業株式会社 | 骨吸収抑制剤 |
| BRPI0606280A2 (pt) * | 2005-03-17 | 2009-06-09 | Elan Pharma Int Ltd | composições de bisfosfonato nanoparticulado |
| JP2007314529A (ja) * | 2006-04-28 | 2007-12-06 | Lion Corp | 造粒粒子、錠剤、及び造粒粒子の製造方法 |
| ES2639854T3 (es) * | 2007-02-01 | 2017-10-30 | Takeda Pharmaceutical Company Limited | Preparación de comprimidos sin causar problemas de fabricación de comprimidos |
| CN102548556A (zh) * | 2009-07-28 | 2012-07-04 | 武田药品工业株式会社 | 片剂 |
-
2012
- 2012-06-20 JP JP2012138410A patent/JP5874545B2/ja active Active
-
2015
- 2015-03-30 JP JP2015068513A patent/JP6142892B2/ja active Active
-
2017
- 2017-02-22 JP JP2017031568A patent/JP2017088626A/ja not_active Withdrawn
-
2018
- 2018-01-22 JP JP2018007905A patent/JP6455611B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018162255A5 (fr) | ||
| RU2018114447A (ru) | Введение дейтерированных усилителей cftr | |
| PH12015502134A1 (en) | Mosapride sustained-release preparation for providing pharmacological and clinical effects with once-a-day administration | |
| EA031255B1 (ru) | Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения | |
| JP2015510916A5 (fr) | ||
| JP2016513724A5 (fr) | ||
| TWI700100B (zh) | 用於口服投藥之包含依澤替米貝（ｅｚｅｔｉｍｉｂｅ）及羅舒伐他汀（ｒｏｓｕｖａｓｔａｔｉｎ）的複合調配物及其製備方法 | |
| JP2017537168A5 (fr) | ||
| JP2014218522A5 (fr) | ||
| SI2729130T1 (en) | Combined formulations of darunavir | |
| JP2014221827A5 (fr) | ||
| HRP20131088T1 (hr) | Äśvrsti farmaceutski pripravci s fiksnom dozom koji sadrže irbesartan i amlodipin, njihova priprava i terapijska primjena | |
| WO2012053785A3 (fr) | Pastilles à libération prolongée contenant du tacrolimus à titre de principe actif | |
| JP2017517551A5 (fr) | ||
| JP2018039810A5 (fr) | ||
| MX2019001032A (es) | Formulacion que tiene caracteristicas mejoradas de liberacion de farmacos ph dependientes, que contienen esomeprazol o una de sus sales farmaceuticas aceptable. | |
| JP2015120758A5 (fr) | ||
| JP2016512247A5 (fr) | ||
| JP2015531749A5 (fr) | ||
| RU2019105711A (ru) | Фармацевтическая композиция, содержащая помалидомид | |
| JP2017523149A5 (fr) | ||
| TWI566786B (zh) | 含有氫化嗎啡酮鹽酸鹽之經口用徐放性醫藥組成物 | |
| JP2017513866A5 (fr) | ||
| JP2017520619A5 (fr) | ||
| RU2020102280A (ru) | Фармацевтическая композиция и способ ее получения |